Cases of respiratory syncytial virus are increasing, but vaccines and antibody shots can keep young children out of the ...
A look at the clinical progress of anti-Aβ monoclonal antibodies and how precision delivery is shaping the next generation of ...
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...
This biotech small-cap's grown its dividend by 140% since 2016! So with an 8.3% yield, is now the time to add it to my Stocks ...
AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers ...
As the FTSE 100 index faces challenges due to weak trade data from China and global economic uncertainties, investors are ...
Alabama recently announced the largest single investment in state history. Eli Lilly, the world's most valuable pharmaceutical company, plans to build a $6 billion advanced manufacturing facility in ...
COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across ...
Data suggest that remote patient monitoring may support outpatient step-up dosing of bispecific antibodies by enabling earlier CRS detection.
Overall, MajesTEC-3 signals a meaningful step forward for combination bispecific therapies in multiple myeloma, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results